Optical Coherence Tomography (OCT) Devices Market

• The Optical Coherence Tomography Market is experiencing increased product demand for several reasons, with one of the primary factors being the growing occurrence of various chronic diseases and the substantial demand for drug discovery related to these conditions.
• The leading Optical Coherence Tomography Companies working in the market include Abbott, Terumo Corporation, ZEISS Group, Leica Microsystems, CANON MEDICAL SYSTEMS EUROPE B.V, Lumedica, Horiba Ltd, Optos (Nikon Co. Ltd), Huvitz Corp, Costruzione Strumenti Oftalmici, HAAG-STREIT GROUP, OPTOPOL Technology Sp. z o.o., Acqiris, Novacam Technologies, Inc., Thorlabs, Inc., Topcon Corporation, SANTEC CORPORATION, Optovue, Incorporated, NIDEK CO., LTD, TOMEY CORPORATION and others

Optical Coherence Tomography Devices Market By Product Type (Time-Dependent Optical Coherence Tomography Devices and Fourier-Dependent Optical Coherence Tomography Devices [Swept-Source Optical Coherence Tomography Devices and Spectral-Domain Optical Coherence Tomography Devices], and Others), Optical Coherence Tomography Devices Market By Medical Specialty (Opthalmology, Cardiology, and Others), Optical Coherence Tomography Devices Market By Application (Clinical Use and Research Use) Optical Coherence Tomography Devices Market By End User (Hospitals, Specialty Clinics, Research Institutes, and Others), Optical Coherence Tomography Devices Market By Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising prevalence of ocular diseases such as cataracts and increasing prevalence of cardiovascular diseases such as acute myocardial infarction.

Global Optical Coherence Tomography Market was valued at USD 1.22 billion in 2023, growing at a CAGR of 8.57% during the forecast period from 2024 to 2030 to reach USD 2.00 billion by 2030. The Optical Coherence Tomography Devices market is moving towards a positive market growth owing to the factors such as rising prevalence of ocular diseases such as cataracts, growing number of cardiovascular diseases such as myocardial infarction, increasing geriatric population across the globe, and increasing product development activities with respect to Optical Coherence Tomography Devices among others.

Optical Coherence Tomography Devices Market Dynamics:

One of the main drivers of the Optical Coherence Tomography Devices Market is the rising prevalence of vision impairment owing to different disease etiologies. As per the data provided by The International Agency for the Prevention of Blindness (IAPB), in 2020, there were about 1.1 billion people across the globe who were suffering from blindness. It was estimated in their research that approximately 2 to 3 billion people require access to healthcare facilities pertaining to eye care in order to optimize their vision and ability to function in society.

Uncorrected refractive errors, cataracts, glaucoma, age-related macular degeneration, and diabetic retinopathy are considered to be the primary causes associated with vision loss. As per the data cited by the World Health Organization, in 2020, cataracts were the prime cause of vision loss in patients above the age of 50 with 15.2 million cases. The increase in the patient population suffering from cataracts is expected to boost the demand for Optical Coherence Tomography Devices as well. This can be ascribed to the fact that Optical Coherence Tomography Market is heavily employed during cataract surgeries for preoperative planning, intraoperative image-based treatments, and postoperative care. Therefore, the rising prevalence of cataracts the growing need to reduce the disease burden of vision impairment is predicted to aid in the growth of the Optical Coherence Tomography Devices market in the forecast period (2024-2030).

Another key factor contributing in the Optical Coherence Tomography Devices Market is increase in demand for Optical Coherence Tomography Devices is the rising prevalence of cardiovascular diseases. For instance, as per the data provided by the World Health Organization (2023), cardiovascular diseases (CVDs) account for the most number of deaths across the globe, accounting for an estimated 17.9 million lives each year. Some of CVDs include myocardial infarction, congestive heart failure, acute coronary syndrome, and other conditions. Furthermore, the same data by the WHO presented that over four out of five CVD deaths list strokes and heart attacks as the main cause, and one-third of these deaths are said to occur prematurely in people below 70 years of age.

In order improve the diagnosis of cardiovascular diseases and reduce the mortality rate, Optical Coherence Tomography Devices technology is now being used in cardiovascular disease diagnosis as well. Optical coherence Optical Coherence Tomography Devices being an intra-coronary diagnostic technique offers a detailed imaging of blood vessels in the current cardiac catheterization laboratory. The higher resolution of Optical Coherence Tomography Devices provides superior delineation of each structure compared to other techniques and it can reliably visualize the microstructure of normal and diseased arteries, thereby contributing to the increased demand for Optical Coherence Tomography Devices during the forecast period from 2024-2030.

However, technology-related limitations as well as high cost of devices compared to other counterparts may restrain the Optical Coherence Tomography devices market growth.

Optical Coherence Tomography Devices Market Segment Analysis:

Optical Coherence Tomography (Optical Coherence Tomography Devices) Devices Market by Product Type (Time-Dependent Optical Coherence Tomography Devices and Fourier-Dependent Optical Coherence Tomography Devices [Swept-Source Optical Coherence Tomography Devices and Spectral-Domain Optical Coherence Tomography Devices], and Others), Optical Coherence Tomography Devices Market by Medical Specialty (Ophthalmology, Cardiology, and Others), Optical Coherence Tomography Devices Market by Application (Clinical Use and Research Use) Optical Coherence Tomography Devices Market by End User (Hospitals, Specialty Clinics, Research Institutes, and Others), and Optical Coherence Tomography Devices Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of Optical Coherence Tomography Market, the swept source optical coherence tomography devices (SS-Optical Coherence Tomography Devices) are estimated to hold a significant share in the Optical Coherence Tomography Devices Market in the forecast period (2024-2030). This can be attributed to the specific features associated with these devices. SS-Optical Coherence Tomography Devices has the advantage that it works without a spectrometer or line camera. SS-Optical Coherence Tomography Devices can operate at long wavelengths, achieve faster image speeds and capture a larger image area than SD-Optical Coherence Tomography Devices. The devices based on this technology work on long wavelengths at 1050 nm which result in less ocular clouding attenuation and an improved depth of field. Commercial SS-Optical Coherence Tomography Devices operate at more than 100,000 scans per second and are finding applications in other clinical specialties such as cardiology, dermatology, and gastroenterology. Moreover, technological advancements in the miniaturization of photonic integrated circuit technology have also contributed in the lowering of costs and compactness of devices as compared to SD-Optical Coherence Tomography Devices systems. The growing popularity of SS-Optical Coherence Tomography Devices systems across various medical specialties is further expected to propel the Optical Coherence Tomography Devices Market growth in the forecast period.

North America is expected to dominate the overall Optical Coherence Tomography Devices Market:

Among all the regions, North America Optical Coherence Tomography Devices Market is expected to account for the largest share in the Optical Coherence Tomography Devices market. Owing to significant growth factors such as rising prevalence of geriatric population, increasing prevalence of risk factors associated with cardiovascular as well as ocular diseases such as obesity, hypertension, and diabetes, rising government initiatives, and increased product launches are expected to aid in the growth of the North America Optical Coherence Tomography Devices Market. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and increased awareness also propelled the market growth in this region.

As per the data provided by the Centers for Disease Control and Prevention, in 2018, approximately 116 million people in the United States suffered from hypertension. Hypertension is considered to be one of the key risk factors for the development of both ocular diseases such as cataracts as well as cardiovascular diseases such as heart stroke among others. Therefore, the presence of large patient population suffering from hypertension correlates to the presence of a high patient population suffering from the progression of these diseases which would indicate the growing need for Optical Coherence Tomography Market that are employed in diseases diagnoses as well as treatment.

Besides the United States, product development activities in other North American countries such as Canada also presents a positive growth environment for the Optical Coherence Tomography devices market in the regions. For instance, in March 2019, Conavi Medical Inc received a Health Canada Medical Device License for their Novasight Hybrid System. This is the only clinical system that allows for the simultaneous imaging of coronary arteries with both intravascular ultrasound (IVUS) and optical coherence tomography (Optical Coherence Tomography Devices). The product launches in the local markets result in significant reduction of costs thereby making them affordable for end users in turn resulting in their high uptake. Therefore, the interplay of various factors such as the presence of large patient population, encouraging reimbursement policies as well as new product launches in the region are going to boost the North America Optical Coherence Tomography Devices market during the forecast period.

Optical Coherence Tomography Companies

Some of the Optical Coherence Tomography Manufacturers operating in the Optical Coherence Tomography Devices market includes Abbott, Terumo Corporation, ZEISS Group, Leica Microsystems, CANON MEDICAL SYSTEMS EUROPE B.V, Lumedica, Horiba Ltd, Optos (Nikon Co. Ltd), Huvitz Corp, Costruzione Strumenti Oftalmici, HAAG-STREIT GROUP, OPTOPOL Technology Sp. z o.o., Acqiris, Novacam Technologies, Inc., Thorlabs, Inc., Topcon Corporation, SANTEC CORPORATION, Optovue, Incorporated, NIDEK CO., LTD, TOMEY CORPORATION and others.

Recent Developmental Activities in Optical Coherence Tomography Devices Market:

• In Optical Coherence Tomography Devicesober 2021, NIDEK CO LTD. launched the Retina Scan Duo 2, a combined Optical Coherence Tomography Devices and fundus camera system. The system comes equipped with new features designed to enhance screening and clinical efficiency, in addition to user-friendly features that were incorporated from the previous model.
• In August 2021, Abbott received the product approval from the US Food and Drug Administration for their optical coherence tomography (Optical Coherence Tomography Devices) imaging platform powered by the company’s new Ultreon imaging software.
• In April 2021, Perimeter Medical Imaging received the Breakthrough Device Designation from the US FDA for their AI’s Optical Coherence Tomography (Optical Coherence Tomography Devices) Imaging System coupled with ImgAssist AI. 

Key Takes Away from the Optical Coherence Tomography Devices Market Report Study:

• Optical Coherence Tomography Devices Market size analysis for current Optical Coherence Tomography Devices market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on Optical Coherence Tomography Devices market is significant. To capture and analyze suitable indicators, our experts are closely watching the Optical Coherence Tomography Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key Optical Coherence Tomography Devices companies dominating the global Optical Coherence Tomography Devices market.
• Various opportunities available for the other competitor in the Optical Coherence Tomography devices market space.
• What are the top performing segments in 2023? How these segments will perform in 2030.
• Which is the top-performing regions and countries in the current Optical Coherence Tomography devices market scenario?
• Which are the regions and countries where Optical Coherence Tomography Devices companies should have concentrated on opportunities for Optical Coherence Tomography Devices Market Growth in the coming future?

Target Audience who can be benefited from this Optical Coherence Tomography Devices Market Report Study

• Optical Coherence Tomography Devices products providers
• Research organizations and consulting Optical Coherence Tomography Devices companies
• Optical Coherence Tomography Devices-related organization, association, forum, and other alliances
• Government and corporate offices
• Start-up Optical Coherence Tomography Devices companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Optical Coherence Tomography Devices market devices
• Various End-users who want to know more about the Optical Coherence Tomography Devices market and latest technological developments in the Optical Coherence Tomography Devices market.

Stay Updated with us @ DelveInsight Blogs